ATE100077T1 - 2-hydroxy-3-phenoxypropylaminoverbindungen. - Google Patents

2-hydroxy-3-phenoxypropylaminoverbindungen.

Info

Publication number
ATE100077T1
ATE100077T1 AT90312043T AT90312043T ATE100077T1 AT E100077 T1 ATE100077 T1 AT E100077T1 AT 90312043 T AT90312043 T AT 90312043T AT 90312043 T AT90312043 T AT 90312043T AT E100077 T1 ATE100077 T1 AT E100077T1
Authority
AT
Austria
Prior art keywords
compounds
phenoxypropylamino
hydroxy
hydrogen
obesity
Prior art date
Application number
AT90312043T
Other languages
English (en)
Inventor
David James Lecount
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Application granted granted Critical
Publication of ATE100077T1 publication Critical patent/ATE100077T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90312043T 1989-11-06 1990-11-02 2-hydroxy-3-phenoxypropylaminoverbindungen. ATE100077T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898925032A GB8925032D0 (en) 1989-11-06 1989-11-06 Chemical compounds
EP90312043A EP0427480B1 (de) 1989-11-06 1990-11-02 2-Hydroxy-3-phenoxypropylaminoverbindungen

Publications (1)

Publication Number Publication Date
ATE100077T1 true ATE100077T1 (de) 1994-01-15

Family

ID=10665813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312043T ATE100077T1 (de) 1989-11-06 1990-11-02 2-hydroxy-3-phenoxypropylaminoverbindungen.

Country Status (10)

Country Link
US (1) US5187190A (de)
EP (1) EP0427480B1 (de)
JP (1) JPH03193747A (de)
AT (1) ATE100077T1 (de)
CA (1) CA2029282A1 (de)
DE (1) DE69005984T2 (de)
ES (1) ES2062407T3 (de)
GB (1) GB8925032D0 (de)
IE (1) IE903751A1 (de)
PT (1) PT95785A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2043552B1 (es) * 1992-05-26 1994-08-01 Asturpharma S A Procedimiento para la preparacion de un derivado de 9, 10-antraquinona y sus sales.
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
WO1994029290A1 (en) * 1993-06-14 1994-12-22 Pfizer Inc. Secondary amines as antidiabetic and antiobesity agents
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
DE69813539T2 (de) * 1997-01-23 2003-12-18 Yamanouchi Pharmaceutical Co., Ltd. Neue amid-derivate und medizinische zusammensetzungen die diese enthalten
US6043253A (en) * 1998-03-03 2000-03-28 Merck & Co., Inc. Fused piperidine substituted arylsulfonamides as β3-agonists
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE368197B (de) * 1968-11-18 1974-06-24 Pfizer
US3903091A (en) * 1970-02-06 1975-09-02 Sumitomo Chemical Co 1,2,3,4-Tetrahydroisoquinoline derivatives
SE354851B (de) * 1970-02-18 1973-03-26 Haessle Ab
GB1387630A (en) * 1971-05-07 1975-03-19 Ici Ltd Phenoxyalkanolamine derivatives
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
SE416545B (sv) * 1976-10-07 1981-01-19 Haessle Ab Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat
US4263323A (en) * 1976-10-07 1981-04-21 Aktiebolaget Hassle β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
CH632987A5 (en) * 1976-10-07 1982-11-15 Haessle Ab Process for preparing novel amines
DD144050A5 (de) * 1978-06-05 1980-09-24 Ciba Geigy Ag Verfahren zur herstellung von n-alkylierten aminoalkoholen
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
SE7807408L (sv) * 1978-06-30 1979-12-31 Haessle Ab Hjertaktiva foreningar
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
EP0028105B1 (de) * 1979-10-25 1983-01-19 Beecham Group Plc Sekundäre Amine, ihre Herstellung und Verwendung in pharmazeutischen Zusammensetzungen
IL65541A0 (en) * 1981-05-06 1982-07-30 Haessle Ab Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
JPS57185243A (en) * 1981-05-08 1982-11-15 Ciba Geigy Ag Substituted 2-aminoethanol
ZA848004B (en) * 1983-10-19 1985-06-26 Hoffmann La Roche Phenoxypropanolamines
GB8415377D0 (en) * 1984-06-15 1984-07-18 Beecham Group Plc Compounds
GB8420837D0 (en) * 1984-08-16 1984-09-19 Beecham Group Plc Compounds
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
US4697033A (en) * 1985-12-24 1987-09-29 Sandoz Ltd. Carbamic and carbamothioic acid esters as pesticides
GB8714901D0 (en) * 1986-07-23 1987-07-29 Ici Plc Amide derivatives
JPS6422898A (en) * 1987-07-17 1989-01-25 Asahi Breweries Ltd 2-alanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivative

Also Published As

Publication number Publication date
EP0427480A1 (de) 1991-05-15
DE69005984D1 (de) 1994-02-24
IE903751A1 (en) 1991-05-08
GB8925032D0 (en) 1989-12-28
JPH03193747A (ja) 1991-08-23
US5187190A (en) 1993-02-16
ES2062407T3 (es) 1994-12-16
PT95785A (pt) 1991-09-13
DE69005984T2 (de) 1994-05-19
CA2029282A1 (en) 1991-05-07
EP0427480B1 (de) 1994-01-12

Similar Documents

Publication Publication Date Title
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
DK543787D0 (da) Antibakterielle midler
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
NO965305D0 (no) Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler
FI893751A0 (fi) Kemiska foereningar.
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DK0479546T3 (da) Piperazinderivater
DK656789A (da) Benzoheterocykliske forbindelser
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
DE69005984D1 (de) 2-Hydroxy-3-phenoxypropylaminoverbindungen.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
IL88657A (en) Preparation of 1-(substituted phenyl)-2-cyclopropylalkanols,novel 1-(substituted phenyl)-3-alkenol derivatives intermediates thereof,and their use as intermediates in the preparation of fungicidal compounds
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
PL287073A1 (en) Method of obtaining novel derivatives of benzanilide
DE69123757D1 (de) Epoxysuccinamidsäurederivat
FI910059A0 (fi) Kemiska foereningar.
NO914192L (no) 8-azabicyklo(3.2.1)oktylalkylthiazolidinoner, fremgangsmaate for fremstilling og anvendelse som medikamenter
PT87310A (pt) Process for the preparation of thiadiazole guanidines
ES2104612T3 (es) Procedimiento de preparacion de derivados de sulfonamida de norbornano.
DE3778088D1 (de) Substituierte pyrimidochinoxaline.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE77373T1 (de) Verfahren zur herstellung von chinolinsaeurederivaten.